Teva Pharmaceutical Industries Limited American Depositary Shares (TEVA)

R&D Expenses

$250.00M

Quarterly · Period ending: Jun 30, 2026 · USD

TEVA R&D Expenses

Latest reported$250.00Mperiod endingJun 30, 2026

TEVA Quarterly R&D Expenses ($0.00 → $250.00M)

Quarterly R&D Expenses

High-resolution chart · PNG

TEVA r&d expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Teva Pharmaceutical Industries Limited American Depositary Shares R&D Expenses — Quarterly (USD)
Period ending	R&D Expenses (USD)
Jun 30, 2026	250,000,000
Mar 31, 2026	222,000,000
Dec 31, 2025	267,000,000
Sep 30, 2025	256,000,000
Jun 30, 2025	244,000,000
Mar 31, 2025	247,000,000
Dec 31, 2024	271,000,000
Sep 30, 2024	240,000,000
Jun 30, 2024	269,000,000
Mar 31, 2024	242,000,000
Dec 31, 2023	234,000,000
Sep 30, 2023	253,000,000
Jun 30, 2023	275,000,000
Mar 31, 2023	253,000,000
Dec 31, 2022	210,000,000
Sep 30, 2022	175,000,000
Jun 30, 2022	228,000,000
Mar 31, 2022	225,000,000
Dec 31, 2021	244,000,000
Sep 30, 2021	222,000,000
Jun 30, 2021	248,000,000
Mar 31, 2021	254,000,000
Dec 31, 2020	382,000,000
Sep 30, 2020	258,000,000
Jun 30, 2020	225,000,000
Mar 31, 2020	221,000,000
Dec 31, 2019	374,000,000
Sep 30, 2019	240,000,000
Jun 30, 2019	276,000,000
Mar 31, 2019	261,000,000
Dec 31, 2018	295,000,000
Sep 30, 2018	311,000,000
Jun 30, 2018	290,000,000
Mar 31, 2018	317,000,000
Dec 31, 2017	360,000,000
Sep 30, 2017	545,000,000
Jun 30, 2017	486,000,000
Mar 31, 2017	457,000,000
Dec 31, 2016	684,000,000
Sep 30, 2016	663,000,000
Jun 30, 2016	375,000,000
Mar 31, 2016	389,000,000
Dec 31, 2015	446,000,000
Sep 30, 2015	361,000,000
Jun 30, 2015	386,000,000
Mar 31, 2015	332,000,000
Dec 31, 2014	379,000,000
Sep 30, 2014	412,000,000
Jun 30, 2014	344,000,000
Mar 31, 2014	353,000,000
Dec 31, 2013	411,000,000
Sep 30, 2013	348,000,000
Jun 30, 2013	339,000,000
Mar 31, 2013	329,000,000
Dec 31, 2012	442,000,000
Sep 30, 2012	324,000,000
Jun 30, 2012	298,000,000
Mar 31, 2012	292,000,000
Dec 31, 2011	386,000,000
Sep 30, 2011	227,000,000
Jun 30, 2011	243,000,000
Mar 31, 2011	239,000,000
Dec 31, 2010	270,000,000
Sep 30, 2010	239,000,000
Jun 30, 2010	217,000,000
Mar 31, 2010	211,000,000
Dec 31, 2009	219,000,000
Sep 30, 2009	195,000,000
Jun 30, 2009	169,000,000
Mar 31, 2009	219,000,000
Dec 31, 2008	1,617,000,000
Sep 30, 2008	194,000,000
Jun 30, 2008	198,000,000
Mar 31, 2008	179,000,000
Dec 31, 2007	168,000,000
Sep 30, 2007	141,000,000
Jun 30, 2007	137,000,000
Mar 31, 2007	135,000,000
Dec 31, 2006	137,300,000
Sep 30, 2006	134,300,000
Jun 30, 2006	120,600,000
Mar 31, 2006	102,800,000
Dec 31, 2005	97,800,000
Sep 30, 2005	92,400,000
Jun 30, 2005	90,500,000
Mar 31, 2005	88,200,000
Dec 31, 2004	92,700,000
Sep 30, 2004	90,400,000
Jun 30, 2004	87,200,000
Mar 31, 2004	68,100,000
Dec 31, 2003	63,800,000
Sep 30, 2003	54,800,000
Jun 30, 2003	48,500,000
Mar 31, 2003	46,400,000
Dec 31, 2002	52,500,000
Sep 30, 2002	40,600,000
Jun 30, 2002	36,800,000
Mar 31, 2002	35,100,000
Dec 31, 2001	29,573,000
Sep 30, 2001	22,500,000